Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2026 07:00 ET | Source: mbiomics GmbH

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

Munich, Germany, April 28, 2026 (GLOBE NEWSWIRE) -- mbiomics GmbH, a pioneering techbio company advancing scalable microbiome-based therapeutics for severe and chronic diseases, today announced the...